These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37338780)

  • 1. Specific nasopharyngeal Corynebacterium strains serve as gatekeepers against SARS-CoV-2 infection.
    Szabo D; Ostorhazi E; Stercz B; Makra N; Penzes K; Kristof K; Antal I; Rethelyi JM; Zsigmond RI; Birtalan E; Merkely B; Tamas L
    Geroscience; 2023 Oct; 45(5):2927-2938. PubMed ID: 37338780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
    Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
    Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
    Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
    EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical Assessment of ACE2 and TMPRSS2 in Nasopharyngeal Swabs from SARS-CoV-2 Patients.
    Peña KB; Gumà J; Guilarte C; Delamo L; Grifol M; Pique B; Hernandez A; Casteñé H; Riu F; Parada D
    Front Biosci (Landmark Ed); 2022 Jul; 27(7):217. PubMed ID: 35866407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Infection is Associated with Age- and Gender-Specific Changes in the Nasopharyngeal Microbiome.
    Bozza S; Nunzi E; Frias-Mazuecos A; Pieraccini G; Pariano M; Renga G; Mencacci A; Talesa VN; Antognelli C; Puccetti P; Romani L; Costantini C
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):59. PubMed ID: 38420819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients.
    Mostafa HH; Fissel JA; Fanelli B; Bergman Y; Gniazdowski V; Dadlani M; Carroll KC; Colwell RR; Simner PJ
    mBio; 2020 Nov; 11(6):. PubMed ID: 33219095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform.
    Mpekoulis G; Frakolaki E; Taka S; Ioannidis A; Vassiliou AG; Kalliampakou KI; Patas K; Karakasiliotis I; Aidinis V; Chatzipanagiotou S; Angelakis E; Vassilacopoulou D; Vassilaki N
    PLoS One; 2021; 16(6):e0253458. PubMed ID: 34185793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
    Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
    J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
    Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corynebacterium accolens Releases Antipneumococcal Free Fatty Acids from Human Nostril and Skin Surface Triacylglycerols.
    Bomar L; Brugger SD; Yost BH; Davies SS; Lemon KP
    mBio; 2016 Jan; 7(1):e01725-15. PubMed ID: 26733066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of ACE, AGTR1, and ACE2 genes mediating SARS-CoV-2 pathogenesis by gut microbiota members and their postbiotics on Caco-2 cells.
    Ahmadi Badi S; Malek A; Paolini A; Rouhollahi Masoumi M; Seyedi SA; Amanzadeh A; Masotti A; Khatami S; Siadat SD
    Microb Pathog; 2022 Dec; 173(Pt A):105798. PubMed ID: 36174833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-Related Changes in the Nasopharyngeal Microbiome Are Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Symptoms Among Children, Adolescents, and Young Adults.
    Hurst JH; McCumber AW; Aquino JN; Rodriguez J; Heston SM; Lugo DJ; Rotta AT; Turner NA; Pfeiffer TS; Gurley TC; Moody MA; Denny TN; Rawls JF; Clark JS; Woods CW; Kelly MS
    Clin Infect Dis; 2022 Aug; 75(1):e928-e937. PubMed ID: 35247047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute severe acute respiratory syndrome coronavirus 2 infection on male hormone profile,
    Huang Z; Do DV; Beh D; Lee CK; Yan B; Foo R; Tambyah PA
    F S Sci; 2022 Feb; 3(1):29-34. PubMed ID: 34841282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the nasopharyngeal microbiome associated with SARS-CoV-2 infection status and disease severity.
    Gauthier NPG; Locher K; MacDonald C; Chorlton SD; Charles M; Manges AR
    PLoS One; 2022; 17(10):e0275815. PubMed ID: 36240246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ACE2, TMPRSS2, and SARS-CoV-2 nucleocapsid protein in gastrointestinal tissues from COVID-19 patients and association with gastrointestinal symptoms.
    Lin L; Zeng F; Mai L; Gao M; Fang Z; Wu B; Huang S; Shi H; He J; Liu Y; Li X; Li Z; Han Y; Yan Z
    Am J Med Sci; 2023 Dec; 366(6):430-437. PubMed ID: 37660993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 infection and replication kinetics in different human cell types: The role of autophagy, cellular metabolism and ACE2 expression.
    Bartolomeo CS; Lemes RMR; Morais RL; Pereria GC; Nunes TA; Costa AJ; de Barros Maciel RM; Braconi CT; Maricato JT; Janini LMR; Okuda LH; Lee KS; Prado CM; Ureshino RP; Stilhano RS
    Life Sci; 2022 Nov; 308():120930. PubMed ID: 36075471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress.
    Rossi ÁD; de Araújo JLF; de Almeida TB; Ribeiro-Alves M; de Almeida Velozo C; Almeida JM; de Carvalho Leitão I; Ferreira SN; da Silva Oliveira J; Alves HJ; Scheid HT; Faffe DS; Galliez RM; de Ávila RE; Resende GG; Teixeira MM; ; da Costa Ferreira Júnior O; Castiñeiras TMPP; Souza RP; Tanuri A; Aguiar RS; Barroso SPC; Cardoso CC
    Sci Rep; 2021 May; 11(1):9658. PubMed ID: 33958627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ILRUN Downregulates ACE2 Expression and Blocks Infection of Human Cells by SARS-CoV-2.
    Tribolet L; Alexander MR; Brice AM; van Vuren PJ; Rootes CL; Mara K; McDonald M; Bruce KL; Gough TJ; Shi S; Cowled C; Bean AGD; Stewart CR
    J Virol; 2021 Jul; 95(15):e0032721. PubMed ID: 33963054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.